Henrik Hasle
Aarhus University · 671 works · 20,496 citations · h-index 76
Top works
- Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
- Risks of leukaemia and solid tumours in individuals with Down's syndrome
- Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)
- A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- Cancer incidence in men with Klinefelter syndrome
- Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling
- Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7
- Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
- Myelodysplastic Syndromes in Childhood—Classification, Epidemiology, and Treatment
- Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents
- Pattern of malignant disorders in individuals with Down's syndrome
- Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
- Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.
- Association between living conditions in childhood and myocardial infarction.
- Long-term results in children with AML: NOPHO-AML Study Group – report of three consecutive trials
- Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO‐AML trials
- Childhood cancer: Survival, treatment modalities, late effects and improvements over time